<DOC>
	<DOCNO>NCT02137733</DOCNO>
	<brief_summary>The purpose study investigate non-inferiority bisoprolol carvedilol evaluate tolerability ( The probability administer maintenance dose reach maximum determined indicator ) primary endpoint bisoprolol carvedilol administer 48 week Japanese chronic heart failure patient . In addition , safety efficacy bisoprolol investigate .</brief_summary>
	<brief_title>The Cardiac Insufficiency BIsoprolol Study Japanese Patients With Chronic Heart Failure ( CIBIS-J )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Bisoprolol</mesh_term>
	<criteria>As result diagnosis test registration , patient consider investigator meet requirement ability consent enrol . 1 . Primary disease : In principle , ischemic heart disease dilate cardiomyopathy . 2 . Heart failure patient 40 % less left ventricular ejection fraction ( LVEF ) . 3 . Patients NYHA functional classification Class II , III , IV ( include medical history ) . 4 . Basic treatment : In principle , patient undergo treatment ACE inhibitor ( angiotensin receptor blocker ( ARB ) ) , diuretic , digitalis preparation , etc . 5 . Patients undergone treatment betablocker ( except eye drop ) within 8 week registration date . 6 . Age : Patients age 20 less 85 day obtain write informed consent . 7 . Hospitalized/outpatient : Either hospitalize outpatient status . 8 . Gender : Male Female Patients meet following exclusion criterion time registration exclude : 1 . Patients consider candidate administration bisoprolol carvedilol . 2 . Patients develop acute myocardial infarction within 8 week registration day . 3 . Patients history stroke serious cerebrovascular accident within 1 year registration day . 4 . Patients poor prognosis lifethreatening disease , malignant tumor , medical history within 5 year registration day . 5 . Patients schedule undergo coronary revascularization ( Coronary artery bypass grafting ; CABG , Percutaneous coronary intervention ; PCI ) study period . 6 . Patients pregnant , lactating , may become pregnant , want become pregnant study . 7 . Patients write informed consent obtain . 8 . Patients judge investigator inappropriate study reason .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>